Regulatory Roundup: St. Jude Resolves Warning Letter; DePuy Synthes Recall; Syphilis Screening Guidance
This article was originally published in The Gray Sheet
Executive Summary
St. Jude Medical resolves neuromodulation device facility warning letter; Depuy Synthes craniomaxillofacial distraction system recall tapped as class I; FDA recommends syphilis screening test policies.